In Vitro Diagnostics Market Research Reports & Industry Analysis
In Vitro Diagnostics Industry Research & Market Reports
-
Latent TB Testing Market by Test Type (Tuberculin Skin Test/TST, IGRA Test), Application (Household Contacts (HHC) of Tuberculosis (TB) Patients, People Living with HIV), End User (Diagnostic Labs, Hospitals), Region - Global Forecast to 2029
... The latent TB testing market will rise in value from estimated USD 582.5 million in 2024 to USD 773.4 million in 2029, at a CAGR of 5.8% over the forecast period. Increased funding and grants ... Read More
-
Legionella Testing
... at a CAGR of 8.2% over the analysis period 2023-2030. Culture Methods, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$122.4 Million by the end of ... Read More
-
Reporter Gene Assays
... by 2030, growing at a CAGR of 6.7% over the analysis period 2023-2030. Luciferase Assays, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$4.1 Billion by ... Read More
-
Bioanalytical Testing Services
... by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Small Molecule Type, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$4.7 Billion ... Read More
-
Predictive Genetic Testing and Consumer Genomics
... the year 2023, is expected to reach US$20.7 Billion by 2030, growing at a CAGR of 14.1% over the analysis period 2023-2030. Predictive Testing, one of the segments analyzed in the report, is expected to ... Read More
-
Prostate Cancer Diagnostics
... by 2030, growing at a CAGR of 13.1% over the analysis period 2023-2030. Preliminary Test, one of the segments analyzed in the report, is expected to record a 12.4% CAGR and reach US$10.0 Billion by ... Read More
-
Rabies Diagnostics
... at a CAGR of 5.3% over the analysis period 2023-2030. Fluorescent Antibody Tests (FAT), one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$910.1 Million by the ... Read More
-
Exocrine Pancreatic Insufficiency
... by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030. Exocrine Pancreatic Insufficiency Therapeutics, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$4.8 ... Read More
-
ATP Assay
... at a CAGR of 7.1% over the analysis period 2023-2030. ATP Assay Consumables & Accessories, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$487.0 Million by ... Read More
-
Over The Counter (OTC) Testing
... is expected to reach US$43.6 Billion by 2030, growing at a CAGR of 9.3% over the analysis period 2023-2030. Glucose Monitoring Tests, one of the segments analyzed in the report, is expected to record a ... Read More
-
Patient Blood Management
... by 2030, growing at a CAGR of 6.4% over the analysis period 2023-2030. Instruments, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$10.1 Billion by the ... Read More
-
Preimplantation Genetic Testing
... by 2030, growing at a CAGR of 9.9% over the analysis period 2023-2030. Reagents & Consumables Component, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$794.1 ... Read More
-
Rapid Microbiology Testing
... by 2030, growing at a CAGR of 7.5% over the analysis period 2023-2030. Rapid Microbiology Testing Instruments, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$4.9 ... Read More
-
Hemostasis Diagnostics
... at a CAGR of 4.8% over the analysis period 2023-2030. Prothrombin Test Time (PT), one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$1.3 Billion by the ... Read More
-
Atomic Spectroscopy
... at a CAGR of 6.9% over the analysis period 2023-2030. Pharmaceuticals & Biotechnology Testing Application, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$6.2 Billion by ... Read More
-
Automated Liquid Handling (ALH) Technologies
... is expected to reach US$3.3 Billion by 2030, growing at a CAGR of 7.8% over the analysis period 2023-2030. Automated Liquid Handling Workstations, one of the segments analyzed in the report, is expected to record ... Read More
-
Veterinary Rapid Testing
... by 2030, growing at a CAGR of 8.1% over the analysis period 2023-2030. Testing Kits, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$1.1 Billion by ... Read More
-
Oncology Based In-Vivo CRO
... reach US$2.5 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Solid Tumors Indication, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and ... Read More
-
Platelet Rich Plasma (PRP)
... reach US$1.6 Billion by 2030, growing at a CAGR of 10.4% over the analysis period 2023-2030. Pure Platelet Rich Plasma, one of the segments analyzed in the report, is expected to record a 10.1% CAGR ... Read More
-
Bio-MEMS
... of 16.8% over the analysis period 2023-2030. Microfluidic Chips, one of the segments analyzed in the report, is expected to record a 17.2% CAGR and reach US$27.4 Billion by the end of the analysis period. ... Read More
-
D-dimer Testing
... at a CAGR of 4.0% over the analysis period 2023-2030. D-dimer Testing Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$1.3 Billion by ... Read More
-
Hemostasis Products
... at a CAGR of 3.8% over the analysis period 2023-2030. Infusible Hemostasis Products, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$8.6 Billion by the end ... Read More
-
Medical Microbiology Testing Technologies
... reach US$3.7 Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2023-2030. Respiratory Diseases Indication, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and ... Read More
-
Microfluidic Device Systems
... by 2030, growing at a CAGR of 19.4% over the analysis period 2023-2030. In-vitro Diagnostics Industry, one of the segments analyzed in the report, is expected to record a 19.4% CAGR and reach US$13.3 Billion ... Read More
-
Hematology Diagnostics
... at a CAGR of 5.8% over the analysis period 2023-2030. Hematology Diagnostics Consumables, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$7.8 Billion by the end ... Read More
Research Assistance
